MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer

NCT03461354 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

49

Enrollment

OTHER

Sponsor class

Stopped Interim analysis indicated study closure

Conditions

Mucositis Oral
Head and Neck Cancer

Interventions

OTHER: MucoLox
OTHER: Sodium Bicarbonate

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]
[object Object]